Illumina Q3 Revenue up 25% on Strong Sequencing Business, Dropping qPCR


Illumina Management Discusses Q3 2013 Results – Earnings Call Transcript


Good day, ladies and gentlemen, and welcome to the Third Quarter 2013 Illumina Inc. Earnings Conference Call. My name is Jackie, and I will be your coordinator today. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes.

I would now like to turn the presentation over to Ms. Rebecca Chambers. Please proceed.

Rebecca Chambers

Thank you, and good afternoon, everyone, and welcome to our earnings call for the third quarter of fiscal year 2013. During the call today, we will review the financial results released after the close of the market and offer commentary on our commercial activity, after which we will host a question-and-answer session. If you have not had a chance to review the earnings release, it can be found in the Investor Relations section of our website at

Participating for Illumina today will be Jay Flatley, President and Chief Executive Officer; Marc Stapley, Senior Vice President and Chief Financial Officer; and Christian Henry, Senior Vice President and General Manager of our Genomic Solutions business. Jay will provide a brief update on the state of our business and Marc will review our third quarter financial results.

(read more…)

Webcast Presentation
Click here for webcast

Scroll To Top